MedPage Today on MSN
Intervention to Get Patients Off Benzos Succeeds in Trial
EMPOWER-ED was a two-arm, individually randomized trial with a 6-month follow-up conducted at Veterans Health Administration ...
A new publication from physicians published in JAMA Psychiatry establishes and clinically describes complex persistent benzodiazepine dependence, or CPBD. Millions of Americans suffering from anxiety ...
The MHRA has strengthened addiction warnings for Z-drugs, benzodiazepines, and gabapentinoids after a review found risks of ...
Millions of Americans suffering from anxiety and insomnia are prescribed a class of sedatives known as benzodiazepines. Known under the popular trade names Xanax, Valium and Ativan, these medications ...
Safety warnings for gabapentinoids, benzodiazepines, and non-benzodiazepines (z drugs) are to be strengthened to give doctors ...
The US Food and Drug Administration (FDA) wants updated boxed warnings on benzodiazepines to reflect the "serious" risks of abuse, misuse, addiction, physical dependence, and withdrawal reactions ...
Anecdotal reports from some professionals have prompted concerns about young people using prescription benzodiazepines such ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results